InvestorsHub Logo
Followers 85
Posts 3543
Boards Moderated 0
Alias Born 12/26/2017

Re: None

Tuesday, 04/24/2018 2:52:18 AM

Tuesday, April 24, 2018 2:52:18 AM

Post# of 111073
Why CMT buyout is very likely to happen

1- Top tier patents, can be applied on many indication.

2- Revolutionary txt for all ED sufferers, with no side effects as Caverstem Tm is not a drug.

3- Derived from own body, therefore no rejection or complication.

4- Stem cell is the future in medical fields.

5- CMT is clearing and extinguishing the debts religiously and diligently , this presents CMT to be an ideal candidate of take over

6- Relatively new and pioneer in stem cell txt for several indication- No pending lawsuit or litigation--clean biotech to be acquired.

7- Caverstem is competing with big pharma's own patent a.k.a. sildenafil citrate- Pharmas will want to control and monopolize the whole ED market.

8- Last but not least....this is the biggest reason...
The biggest factor is the recently passed US tax reforms by Trump's administration, which reduce corporation tax from 35% to 21%, bringing the country much closer to comparable advanced economies.

US companies will also no longer have to pay corporate taxes on income earned overseas – these will be taxed between 8 and 15.5% instead of the current 35%, allowing pharma to repatriate billions.

This provides American corporations with a massive windfall, which big pharmas will spend on share buybacks, raising dividends and M&A.----Merger and Acquisition OF SMALL CAPS BIOTECH COMPANIES----gaining market share, raises outlook--This is where CMT will fit in the big picture.
CMT IS AT THE RIGHT TIME, RIGHT PLACE, RIGHT SECTOR.

CMT is making all the right moves, reducing debts, marketing the patents, working hard to attract more investors, getting PPS to a respectable level, --the tell tales signs all pointing toward a CLEAR objective---M&A.


It is not a matter of when, but how soon, and how much.

More info on M&A on biotech / Pharmas / Medical companies

https://www.thepharmaletter.com/listing/mergers-acquisitions/biotechnology?tagid[]=7082

SO FOLKS, DO YOUR OWN DD, CMT IS NOT A GAME CHANGER.
THIS IS A LIFE CHANGER.

ABSOLUTELY NO PUMPING AND PIMPING.
JUST FACTS.












GLTA


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News